Probiotic-based Life-extension therapy: Probiotic lactobacillus reuteri  inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 25/December/2018, 10.26 pm

Life-extension therapy: Troglitazone (brand name: Rezulin, Resulin, Romozin, Noscal), an anti-diabetic and anti-inflammatory drug,  inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 25/December/2018, 5.55 pm
December 25, 2018
Probiotic-based chemotherapy targeting cancer stem cells and immune-inhibitory receptors in advanced metastatic cancers: A pharmaceutical mixture encompassing   SAHA (Suberoylanilide Hydroxamic Acid) and probiotic Lactobacillus rhamnosus increases the expression of tumor suppressor genes, such as APAF1 and PIAS3, p53, and TA-p73/p63, inhibits immune-inhibitory receptors/molecules, targets cancer stem cells, confers protection against chemoresistance and prolongs survival, via up-regulation of its target gene, 26/December/2018, `6.31 pm
December 26, 2018
Show all

What they say:

A study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal protein S6 kinase 1 signaling regulates mammalian life span.” This study was published, in the 2 October 2009 issue of the Journal “Science”           (I.F: 31.477 ), by Prof Dominic J. Withers, Dr. Selman C and others.


What we say: 

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports, for the first time, that: Probiotic-based Life-extension therapy: Probiotic lactobacillus reuteri  inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span



Research findings to Therapeutic opportunity: 

Probiotic lactobacillus reuteri, by  increasing  the expression of its target gene, it may suppress Ribosomal protein S6 kinase 1 (p70S6 Kinase) expression. Thereby, it may promote: (1) resistance to bone, immune, and motor dysfunction; (2) insulin sensitivity; and (3) longevity (fig. 1).

Figure 1. Mechanistic insight into how probiotic lactobacillus reuteri may extend lifespan. Probiotic lactobacillus reuteri inhibits p70 S6 kInase expression and promotes longevity.

Figure 2. Probiotic lactobacillus reuteri functions as a longevity promoter by down regulating the expression of p70S6 kinase.

[easy_payment currency=”USD”]

Thus, pharmacological formulations encompassing “probiotic lactobacillus reuteri, either alone or in combination with any of the known longevity-promoting compound(s),” may be used to extend the lifespan of an individual (fig. 1).


Details of the research findings: 

Idea Proposed/Formulated (with experimental evidence) byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic Information: How does Probiotic lactobacillus reuteri decrease the expression of p70 S6 Kinase? 

# Research cooperation

Amount: $100#

For purchase and payment information, you may reach us at info@genomediscovery.org


References:

CitationBoominathan, L., Probiotic-based Life-extension therapy: Probiotic lactobacillus reuteri  inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 25/December/2018, 10.26 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or newbioideas.com/

Courtesy: When you cite, drop us a line at info@genomediscovery.org

Comments are closed.